Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: EARNINGS

Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2023 Financial and Operational Results


SALINAS, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the "Company") (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, manufacturing, sales and brand management, announces audited revenue and operating results for the fourth quarter and fiscal year (ended December 31, 2023). All figures stated are in US Dollars.

Fourth Quarter and Fiscal Year Financial Highlights:

Revenue Summary ($'s in ?000)
      
     Q4'23 vs Q3'23
 Q4'22Q3'23Q4'23 Growth
CPG Revenues$5,682$4,369$4,582 5%
Bulk Product$2,768$1,196$1,984 66%
LFS$549$455$918 102%
Out-of-State Licensing$289$192$11 -94%
Total$9,288$6,212$7,495 21%
         

"As we move through 2024, Lowell stands today as a restructured company. The challenges of the past year have been formidable, but our team's resilience and determination have propelled us through," said Co-Founder and Chief Executive Officer Mark Ainsworth. "Our strategic decisions have now positioned us favorably and we expect to see a positive impact on the company in the quarters ahead. With our focus sharpened and our foundation strengthened, we are grateful to remain in this ever-evolving landscape that is the California cannabis industry."

Subsequent events to the fourth quarter ended December 31, 2023:

Operational Highlights and Ongoing Initiatives:

Q4 and Year End Financial Results Earnings Conference Call Details:
The conference call with management at 8:30 a.m. EDT on Thursday, March 28, can be accessed using the following dial-in information:

U.S. and Canadian Toll Free: 1-800-274-8461
International: 1-203-518-9814
Webcast: Link here
   

Please dial-in at least 10 minutes before the call to register.

The conference call will be webcast live and archived on the investor relations section of the Lowell Farms website at https://ir.lowellfarms.com/.

ABOUT LOWELL FARMS INC.
Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF) (the "Company") is a California-based cannabis company with advanced production capabilities supporting the supply chain, including extraction, manufacturing, brand sales, marketing, and distribution. Lowell Farms has an exclusive portfolio of award-winning brands, including Lowell Herb Co, House Weed, Moon, Cypress Cannabis, and Original Pot Co. for licensed retailers statewide.

Lowell Farms Inc. Media Contact
[email protected]

Lowell Farms Inc. Investor Relations Contact
Bill Mitoulas
416.479.9547
[email protected]

Lowell Farms Inc. Company Contact
Mark Ainsworth
[email protected]

Forward-Looking Information and Statements
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved." The forward-looking information and forward-looking statements contained herein may include, but are not limited to, the anticipated growth of Lowell Farm Services and the ability of the Company to successfully achieve its business objectives and expectations for other economic, business, and/or competitive factors. There can be no assurance that such forward-looking information and statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information and statements. This forward-looking information and statements reflect the Company's current beliefs and are based on information currently available to the Company and on assumptions the Company believes are reasonable.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; operating and development costs; competition; changes in legislation or regulations affecting the Company; the timing and availability of external financing on acceptable terms; the available funds of the Company and the anticipated use of such funds; favorable production levels and outputs; the stability of pricing of cannabis products; the level of demand for cannabis product; the availability of third-party service providers and other inputs for the Company's operations; lack of qualified, skilled labor or loss of key individuals; and risks and delays resulting from the COVID-19 pandemic. A description of additional assumptions used to develop such forward-looking information and a description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company's disclosure documents, such as the Company's annual information form filed on the SEDAR website at www.sedar.com and the Company's Form 10 filed on the SEC website at www.sec.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement.

The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed, or accepts responsibility for the adequacy or accuracy of, the content of this news release.

Use of Non-GAAP Financial Information

EBITDA is net income (loss), excluding the effects of income taxes (recovery)? net interest expense? depreciation and amortization? and adjusted EBITDA also includes noncash fair value adjustments on investments? unrealized foreign currency gains/losses? share-based compensation expense? and other transactional and special expenses, such as out-of-period insurance recoveries and acquisition costs and expenses related to the markup of acquired finished goods inventory, which are inconsistent in amount and frequency and are not what we consider as typical of our continuing operations. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by operations. We use adjusted EBITDA internally to understand, manage, make operating decisions related to cash flow generated from operations and evaluate our business. In addition, we use adjusted EBITDA to help plan and forecast future periods.

This measure is not necessarily comparable to similarly titled measures used by other companies.

A reconciliation of this measure to Net Loss is provided below.

LOWELL FARMS INC.
CONSOLIDATED BALANCE SHEETS
 
  December 31,  December 31, 
  2023  2022 
ASSETS      
Current assets:      
Cash and cash equivalents $2,311  $1,098 
Accounts Receivable - net of allowance for doubtful accounts of $959 and $1,053 at December 31, 2023 and December 31, 2022, respectively  2,620   4,163 
Inventory  4,760   10,779 
Prepaid expenses and other current assets  2,397   1,522 
Total current assets  12,088   17,562 
Property and equipment, net  4,099   31,284 
Right of use assets, net  18,327   27,362 
Other intangibles, net  2,544   42,202 
Other assets  555   413 
         
Total assets $37,613  $118,823 
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
Current liabilities:        
Accounts payable $4,314  $2,307 
Accrued payroll and benefits  363   350 
Notes payable, current portion  3   282 
Lease obligation, current portion  1,990   2,659 
Convertible debentures  -   21,398 
Other current liabilities  1,943   3,654 
Total current liabilities  8,613   30,650 
Notes payable  -   3 
Lease obligation  17,522   31,340 
Convertible debentures  -   - 
Mortgage obligation  -   8,713 
Total liabilities  26,135   70,706 
COMMITMENTS AND CONTINGENCIES        
STOCKHOLDERS' EQUITY        
Share capital  192,445   191,742 
Accumulated deficit  (180,967)  (143,625)
Total stockholders' equity  11,478   48,117 
         
Total liabilities and stockholders' equity $37,613  $118,823 

 

LOWELL FARMS INC.
CONSOLIDATED STATEMENTS OF INCOME (LOSS)
 
  Years Ended 
  December 31,  December 31, 
  2023  2022 
Net revenue $28,265  $43,535 
Cost of goods sold  35,707   45,376 
         
Gross profit (loss)  (7,442)  (1,841)
         
Operating expenses        
General and administrative  7,302   9,553 
Sales and marketing  2,397   5,274 
Depreciation and amortization  421   448 
Total operating expenses  10,120   15,275 
         
Loss from operations  (17,562)  (17,116)
         
Other income/(expense)        
Other income (expense)  8,541   2,455 
Unrealized loss on change in fair value of investment  (28)  (109)
Impairment expense of long-lived assets  (24,295)  (3,240)
Interest expense  (3,837)  (6,363)
Total other income (expense)  (19,619)  (7,257)
         
Loss before provision for income taxes  (37,181)  (24,373)
Provision for income taxes  161   191 
Net loss $(37,342) $(24,564)
         
Net loss per share:        
Basic $(2.71) $(2.17)
Diluted $(2.71) $(2.17)
Weighted average shares outstanding:        
Basic  13,790   11,318 
Diluted  13,790   11,318 

 

LOWELL FARMS INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
  Years Ended 
  December 31,  December 31, 
  2023  2022 
CASH FLOW FROM OPERATING ACTIVITIES      
Net loss $(37,342) $(24,564)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization  5,117   7,376 
Amortization of debt issuance costs  712   937 
Share-based compensation expense  231   564 
Provision for doubtful accounts  616   517 
Loss on sale of assets  -   59 
Gain on sale leaseback  (3,004)  - 
Gain on lease settlement  (880)  - 
Unrealized loss (gain) on change in fair value of investments  28   109)
Impairment expense  24,295   3,240 
Gain on lease termination  (5,020)  - 
Changes in operating assets and liabilities:        
Accounts receivable  927   3,542 
Inventory  6,019   2,564 
Prepaid expenses and other current assets  2,731   454 
Other assets  (270)  (106)
Operating lease liabilities  (443)  - 
Accounts payable and accrued expenses  242   (1,136)
Net cash used in operating activities $(6,041) $(6,444)
CASH FLOW FROM INVESTING ACTIVITIES        
Proceeds from asset sales $-  $60 
Purchases of property and equipment  (135)  (4,250)
Acquisition of business assets, net  -  - 
Net cash used in investing activities $(135) $(4,190)
CASH FLOW FROM FINANCING ACTIVITIES        
Proceeds from convertible notes, net of financing costs $-  $6,552 
Principal payments on finance lease obligations  (1,527)  (2,497)
Payments on notes payable  (75)  (210)
Proceeds from sale leaseback  8,991   - 
Issuance costs related to subordinate voting share offering  -  - 
Proceeds from exercise of warrants and options  -   - 
Net cash provided by financing activities $7,389  $3,845 
         
Change in cash and cash equivalents $1,213  $(6,789)
Cash and cash equivalents-beginning of year  1,098   7,887 
Cash, cash equivalents-end of period $2,311  $1,098 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION        
Cash paid during the period for interest $3,689  $4,215 
Cash paid during the period for income taxes $87  $171 
         
OTHER NONCASH INVESTING AND FINANCING ACTIVITIES        
Purchase of property and equipment not yet paid for $7  $819 
Issuance of subordinate voting shares to acquire purchase rights $-  $1,800 
Issuance of subordinate voting shares in convertible debenture repurchase $2,027  $- 


The table below reconciles Net Loss to Adjusted EBITDA
 for the periods indicated.


LOWELL FARMS INC.
EBITDA - Non-GAAP measure
 
  Three Months Ended  Years Ended  
  December 31,  December 31,  December 31,  December 31,  
(in thousands) 2023  2022  2023  2022  
Net loss $(13,059) $(11,114) $(37,342) $(24,564) 
Interest expense(2)  (567)  1,495   3,837   5,499  
Provision for income taxes  1   (34)  161   191  
Depreciation and amortization in cost of goods sold  861   1,904   4,696   6,320  
Depreciation and amortization in operating expenses  105   107   421   448  
Depreciation and amortization in other income (expense)      190   -   608  
EBITDA(1)  (12,659)  (7,452)  (28,227)  (11,498) 
Investment and currency losses  -   7   30   130  
Goodwill Impairment      3,240          
Inventory revaluation  -   -   (157)  -  
Impairment Expense  2,267   -   2,267   3,240  
Debt Repurchase Charges(3)  (548)  -   13,477   -  
Impairment on Cultivation Facility  6,822   -   6,822   -  
Share-based compensation  38   137   231   564  
Other charges(2) (4) (5)          (2,161)  (1,984) 
Adjusted EBITDA(1) $(4,080) $(4,068) $(7,718) $(9,548) 
       
     
(1) Non-GAAP measure
(2) In 2022, net of $864 of financing charges related to the ERC claim, reclassified from interest expense on the Condensed Consolidated Statements of Income (Loss) to transaction and other special charges in the Adjusted EBITDA table.
(3) Comprised of $13,245 of impairment charges on intangible assets and $232 of legal expenses incurred in the year ending December 31, 2023 related to the debt settlement and asset sale. All charges were included in other income (expense) on the Condensed Consolidated Statements of Income (Loss).
(4) For the year ended December 31, 2023, reflects a one time, non-recurring adjustment to prior period yield and processing variances on the Company's processing facility, included in cost of goods sold on the Condensed Consolidated Statements of Income (Loss)
(5) Includes a $3,884 gain on lease transactions during the year. All charges were included in other income (expense) on the Condensed Consolidated Statements of Income (Loss).


These press releases may also interest you

at 08:05
Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented positive data from three key studies of its infectious disease franchise at the European...

26 avr 2024
KIND, KVSB DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Investors to Secure Counsel Before Important April 29 Deadline in Securities Class Action - KIND, KVSB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II between July 6, 2021 and November 8, 2022, both dates inclusive (the "Class...

26 avr 2024
Latin America CDC a Must, say Public Health Leaders and AHF
In response to the unprecedented challenges that Latin America has faced during various health crises such as AH1N1, Zika, COVID-19, and Dengue, a prominent group of former health ministers and public health academics from the region has published in...

26 avr 2024
SIMPLY BETTER BRANDS CORP. ANNOUNCES ISSUANCE OF SHARES PURSUANT TO VIBEZ AGREEMENT
Simply Better Brands Corp. ("SBBC" or the "Company") announces that, further to the Company's news release dated January 25, 2023, and in connection with the Branding Earnout Agreement dated January 25, 2023, the Company has issued 89,966 common...

26 avr 2024
CHEGG INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Chegg, Inc. - CHGG
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Chegg, Inc. . Chegg is a publicly traded educational technology...

26 avr 2024
Whitman-Walker Institute Applauds the Biden-Harris Administration for Finalizing Robust Affordable Care Act Nondiscrimination Protections for LGBTQI+ Communities
Today, the Biden-Harris Administration released a final rule under Section 1557, the core nondiscrimination provision of the Affordable Care Act. This groundbreaking rule marks a critical step in protecting access to health care and coverage for...

More news about Covid-19 virus...


News published on and distributed by: